drugset

drugset / Trial / NCT02159859

Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients

NCT02159859 ↗

Phase 2 Completed 7 enrolled Corewell Health East Wayne State University · collab

NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to determine the amount of ertapenem in the blood over time between hemodialysis session.

Timeline

Start: 2014-12
Primary completion: 2016-04
Completion: 2016-04

Publications

Results Hsaiky LM, Salinitri FD, Wong J, Jennings ST, Desai NH, Lobkovich AM, Cha R. Pharmacokinetics and investigation of optimal dose ertapenem in intermittent hemodialysis patients. Nephrol Dial Transplant. 2019 Oct 1;34(10):1766-1772. doi: 10.1093/ndt/gfy166.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ertapenem	Small molecule	1 g	Intravenous

Indications